Skip to content

RoosterBio Logo

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • Human Primary Cells
      • Bone Marrow-derived hMSCs
      • Adipose-derived hMSCs
      • Umbilical Cord-derived hMSCs
      • Human Dermal Fibroblasts
      • QuickShip™ Cell Banks
    • Cell & Exosome Media
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • QuickShip™ MSC & Exosome Media
    • Genetic Engineering Tools
      • Genetic Engineering Media
    • Human Exosomes / Extracellular Vesicles
      • MSC-Derived Exosomes
      • QuickShip™ Exosomes
      • QuickShip™ Downstream Processing
    • Cell & Media Kits
      • hMSC Starter Kits
      • hMSC Donor & Tissue Screening Kits
      • hMSC & Exosome Bioreactor Kits
    • cGMP CliniControl™ Products
      • Human Mesenchymal Stem / Stromal Cells (hMSCs)
      • hMSC Expansion Media
      • hMSC Bioreactor Feed
      • Exosome Media
      • Genetic Engineering Media
  • Services
    • Process Development Services
    • hMSC Analytical Services
    • Exosome/Extracellular Vesicle Analytical Services
    • QuickShip™ Solutions
  • Knowledge Center
    • Resources
    • CoAs & QC Briefs
    • Publications
    • Videos & Webinars
    • Blog Articles
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
    • FAQs
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Publications

Good Manufacturing Practice-grade fibronectin for hollow-fiber bioreactor cell manufacture: a mesenchymal stromal cell case study

December 2024 Bioprinting, Bioprocessing, Blood, Cell Therapy, Clinical, Gene Editing, Tissue Engineering

Stepwise Stiffening/Softening of and Cell Recovery from Reversibly Formulated Hydrogel Interpenetrating Networks

November 2024 Bioprinting, Cancer, Exosomes / Extracellular Vesicles, Gene Editing, MedTech, Devices, & Materials, Tissue Engineering

Connexin 43 regulates intercellular mitochondrial transfer from human mesenchymal stromal cells to chondrocytes

October 2024 Bioprinting, Bioprocessing, Cell Therapy, Gene Editing, Tissue Engineering

Modeling integration site data for safety assessment with MELISSA

October 2024 Bioprinting, Bioprocessing, Blood, Cell Therapy, Clinical, Gene Editing, Tissue Engineering

Intratumoral Delivery of Genetically Engineered Anti-IL-6 Trans-signaling Therapeutics

July 2024 Cancer, Cell Therapy, Clinical, Gene Editing, Genetic, Immunomodulation

Innovative Platforms for Macrophage Behavior: Establishment of Stable Macrophage Reporters And Macrophage-Incorporated Airway Organoid

July 2024 Bioprinting, Bioprocessing, Cancer, Cell Therapy, Dermal and Wound, Gene Editing, Immunomodulation, Lung, Tissue Engineering

Localized Gene Delivery and Enhanced Cell-Cell Communication via Bio-Orthogonal Polymer Coatings

July 2024 Bioprinting, Bioprocessing, Gene Editing, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

MMP-9 enhanced Mesenchymal stem cells for the treatment of liver fibrosis

June 2024 Bioprinting, Bioprocessing, Cell Therapy, Clinical, Gene Editing, Genetic, Immunomodulation, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

A 3D Printed Bioreactor Enables AUTOMATED AND SCALABLE MANUFACTURING OF MESENCHYMAL STEM CELLS (MSCS) AND MSC-DERIVED EXOSOMES

June 2024 Bioprinting, Bioprocessing, Cell Therapy, Exosomes / Extracellular Vesicles, Gene Editing, Immunomodulation, MedTech, Devices, & Materials, Orthopedic, Tissue Engineering

BLOOD-COMPATIBLE ENDOMETRIAL MESENCHYMAL STEM CELLS FOR CLINICAL APPLICATION

June 2024 Bioprinting, Bioprocessing, Blood, Cardiovascular, Cell Therapy, Clinical, Exosomes / Extracellular Vesicles, Gene Editing, Immunomodulation, Tissue Engineering
1 2 3 4 Next

Sidebar Navigation

  • Bioprinting
  • Bioprocessing
  • Blood
  • Cancer
  • Cardiovascular
  • Cell Therapy
  • Clinical
  • Dermal and Wound
  • Diabetes
  • Drug Screening
  • Exosomes / Extracellular Vesicles
  • Gene Editing
  • Genetic
  • Immunomodulation
  • Lung
  • MedTech, Devices, & Materials
  • Orthopedic
  • Pain
  • Pulmonary
  • Renal
  • Tech Segment
  • Therapeutic Indication
  • Tissue Engineering

Contact Information

RoosterBio, Inc.
5295 Westview Drive, Suite 275
Frederick, MD 21703
Customer Service: +1 240-831-4914
Headquarters: +1 301-200-5366
Email: info@roosterbio.com

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn

Footer Navigation

  • Our Technology
  • Services
  • About Us
  • News & Events
  • Contact Us
  • Login
  • Products
    • Human Primary Cells
    • Cell & Exosome Media
    • Human Exosomes / Extracellular Vesicles
    • Genetic Engineering Tools
    • Cell & Media Kits
    • cGMP CliniControl™ Products
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
    • Videos & Webinars

Copyright © 2025 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Celerate

  • Share on Facebook
  • Tweet
  • Share on LinkedIn
  • Email